GLP-3 R 20MG
Retatrutide 20mg is a high-purity multi-agonist research peptide targeting GLP-1, GIP, and glucagon receptors. Designed for advanced metabolic and obesity research, it supports investigation into energy balance, glucose regulation, and endocrine signaling. Supplied as a lyophilized powder for controlled laboratory applications only. Strictly for research use, not for human consumption
$175.00
Satisfaction Guaranteed
Secure
Payment
Third-party
Tested
⚠️ RESEARCH USE ONLY
This product is for R&D purposes only and is not approved for human or veterinary use.
Retatrutide 20mg – Multi-Agonist Peptide for Metabolic Research
Quantum Biogenix presents research-grade Retatrutide 20mg, a novel multi-receptor agonist peptide developed for advanced metabolic and endocrine research. Retatrutide is designed to activate GLP-1, GIP, and glucagon receptors, enabling comprehensive investigation into energy balance, glucose regulation, and lipid metabolism within controlled laboratory environments.
As a next-generation metabolic research compound, Retatrutide allows researchers to explore synergistic hormone signaling pathways involved in appetite regulation, insulin sensitivity, and energy expenditure. Its multi-agonist profile makes it a valuable tool for studying complex metabolic adaptations and obesity-related mechanisms in experimental models.
| Product Name | Retatrutide |
| Category | Multi-Agonist Peptide Research Compound |
| Form | Lyophilized Peptide Powder |
| Content | 20mg |
| Purity | ≥98% (HPLC Verified) |
| Application | Metabolic, Endocrine & Obesity Research |
| Usage | Laboratory Research Only |
Scientific Overview of Retatrutide
- Triple receptor agonist targeting GLP-1, GIP, and glucagon pathways
- Supports investigation of appetite regulation and energy balance
- Modulates glucose metabolism and insulin signaling pathways
- Used in advanced obesity and metabolic disorder research models
- High-purity peptide suitable for controlled laboratory studies
Key Research Applications
- Obesity Research Models – Evaluation of combined hormonal signaling effects on body weight regulation and fat mass.
- Glucose Homeostasis Studies – Investigation of insulin sensitivity, glucose uptake, and glycemic control mechanisms.
- Energy Expenditure Analysis – Assessment of metabolic rate and thermogenic pathway modulation.
- Appetite & Satiety Research – Study of central and peripheral signaling involved in feeding behavior.
- Endocrine Pathway Research – Examination of multi-receptor peptide interactions in metabolic regulation.
Laboratory Handling & Storage
- Form: Lyophilized peptide powder
- Purity: ≥98% (HPLC verified)
- Recommended Storage: Store frozen or refrigerated, protected from light and moisture
- Handling: Reconstitute using laboratory-grade solvents under sterile conditions
- Stability: Maintain sealed and dry until research use
Mechanism of Research Interest
Retatrutide functions as a multi-agonist peptide by simultaneously activating GLP-1, GIP, and glucagon receptors. This combined receptor activity allows researchers to study integrated metabolic signaling networks that regulate appetite, glucose utilization, lipid metabolism, and energy expenditure. Experimental research suggests that multi-receptor activation may produce distinct metabolic adaptations compared to single-pathway compounds, making Retatrutide a powerful tool for investigating complex metabolic disease models and energy regulation mechanisms.
Why Choose Quantum Biogenix?
- High-purity research peptides
- Batch-tested laboratory-grade compounds
- Strict quality control and verification standards
- Research-focused formulation practices
- Professional laboratory supply chain handling
Research Use Only Notice
This product is supplied strictly for laboratory research use only. It is not intended for human consumption, medical treatment, or veterinary application. All handling and experimentation must comply with institutional safety and research regulations.
Scientific References
- Coskun T. et al. (2022). Multi-agonist peptides for metabolic disease treatment. Cell Metabolism.
- Finan B. et al. (2021). Targeting multiple metabolic pathways with peptide therapeutics. Nature Reviews Drug Discovery.
- Müller T.D. et al. (2019). Hormonal control of energy balance and metabolism. Nature Metabolism.
Reviews
There are no reviews yet.